Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
AVN944 in Pancreatic Cancer
NCT00493441Phase 2Terminated
- Sponsor
- Vertex Pharmaceuticals
- Start
- Jun 2007
- Primary completion
- Dec 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of AVN-944 in pancreatic adenocarcinoma (PDAC), sponsored by Vertex Pharmaceuticals. Started Jun 2007; status: terminated.
02
Drugs
AVN-944
03
Conditions
pancreatic adenocarcinoma (PDAC)
Beyond the preview
Go deeper on NCT00493441.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00493441.